Instrumento Inactivo

Otros idiomas Portola Pharmaceuticals, Inc.

Acciones

US7370101088

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

PORTOLA PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	02/07/20
Portola Pharmaceuticals, Inc.(NasdaqGS:PTLA) dropped from S&P Biotechnology Select Industry Index	02/07/20
Portola Pharmaceuticals, Inc.(NasdaqGS:PTLA) dropped from S&P TMI Index	02/07/20
Portola Pharmaceuticals, Inc.(NasdaqGS:PTLA) dropped from S&P Global BMI Index	02/07/20
Alexion Pharmaceuticals, Inc. completed the acquisition of the remaining 96.6% stake in Portola Pharmaceuticals, Inc..	01/07/20
Portola Pharmaceuticals : Amendment to a previously filed SC TO-T	30/06/20
Portola Pharmaceuticals : Amendment to a previously filed SC 14D9	30/06/20
PORTOLA PHARMACEUTICALS INC : Other Events (form 8-K)	17/06/20
Portola Pharmaceuticals, Inc. Receives Written Notice of Termination from Bayer AG	17/06/20
PORTOLA PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holders (form 8-K)	15/06/20
Portola Pharmaceuticals : Announces Virtual 2020 Annual Stockholder Meeting	19/05/20
Portola Pharmaceuticals : U.S. Centers for Medicare and Medicaid Services Proposes Extending New Technology Add-on Payment Reimbursement	15/05/20
Portola Pharmaceuticals : U.S. Centers for Medicare & Medicaid Services (CMS) Proposes Extending New Technology Add-on Payment (NTAP) Reimbursement for Portola Pharmaceuticals' Andexxa® for Third Year	14/05/20
PORTOLA PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	11/05/20
Portola Pharmaceuticals: 1Q Earnings Snapshot	11/05/20
Portola Pharmaceuticals : Reports First Quarter 2020 Financial Results and Provides Corporate Update	11/05/20
Portola Pharmaceuticals, Inc. Suspends Prior Guidance for Approximately 350 New Hospital Adds in 2020	11/05/20
Portola Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	11/05/20
PORTOLA PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	07/05/20
WeissLaw LLP Investigates Portola Pharmaceuticals, Inc.	06/05/20

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Portola Pharmaceuticals, Inc.

Acciones

US7370101088

Otros idiomas

Filtros